Healing Islands: Invest in the Caribbean’s First Evidence-Based Wellness Retreat + Renal Internship Hub

Business Plan

Revenue StreamPriceGross MarginLaunch-Year Mix*3-Week Renal Fellowship$5,295 / student80 %35 %7-Day Wellness Retreat$2,800 / guest week85 %55 %Add-On Labs & Culinary$300 avg.90 %5 %Corporate / CEU Weeks$35 K / campus week70 %3 %Digital Course Licensing$199 / user95 %2 %

*One 12-bed villa in Barbados reaches breakeven at 40 % utilization; a copy-paste playbook expands to Jamaica, St Lucia, and beyond.

Target Markets

• 5 M+ global health-science students competing for <1 % of international renal rotations.

• $4.2 B Caribbean wellness-tourism spend, growing 12.7 % CAGR.

Investor Fit
Mission-aligned angels, family offices, and impact VCs seeking cash-flow participation and measurable health outcomes.

Team

• Dr. Anika Avery-Grant, CEO – Doctor of Clinical Nutrition, Certified Renal Specialist, 20+ years in hospitals, universities, and community programs; published author and former director of a multimillion-dollar nutrition services unit.

• Ekene Avery, COO (25 % owner) – Bioinformatics and IT professional providing legal, financial, and operational oversight.

• Siena Mauge, Program Assistant – Administrative backbone ensuring seamless student and guest experiences.

Supported by advisors in nursing, real-estate, and Caribbean health policy.

Competitive Advantage

1. Only ACEND-level renal curriculum in the Caribbean led by a board-certified doctor.

2. Dual-market asset utilization—intern cohorts fill dorms May–Aug; wellness guests fill suites Sep–Apr, driving year-round 75 % occupancy versus the regional 40 % average.

3. Mission moat—government SDG alignment secures subsidies and goodwill no luxury spa can replicate.

Why Now

• Wellness-tourism boom: Global travelers now spend 59 % more per trip for health-oriented experiences.

• Post-COVID education rebound: U.S. study-abroad volume jumped 49 % YoY; universities urgently need non-European programs.

• CKD crisis: Barbados owns some of the world’s worst renal-disease statistics—local demand and regulatory urgency are at an inflection point.

Deal Terms

ItemDetailRaise$500 K – $600 K revenue-share note (or SAFE/convertible structure by negotiation)Investor Return% of annual gross income until 1.5× principal repaid (illustrative)Use of FundsFinish construction (≈ $400 K), van down-payment, working capital, staff ramp-upTimelineCampus completion & first cohort within 5 months of fundingExit PathsSeries-A roll-up of Caribbean campuses / acquisition by wellness-hospitality chain / income buy-out

Flexible terms allow early supporters to participate directly in top-line growth while preserving community impact.